Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease
Authors
Keywords
-
Journal
INTERNATIONAL UROLOGY AND NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-26
DOI
10.1007/s11255-020-02509-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
- (2019) Chia Lin Chang et al. Scientific Reports
- Aerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats
- (2019) Jeong Rim Ko et al. Journal of Clinical Medicine
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity
- (2019) Min Wang et al. ANNALS OF NUTRITION AND METABOLISM
- Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
- (2019) Xinyue Zhang et al. Journal of Diabetes Investigation
- Update of pathophysiology and management of diabetic kidney disease
- (2018) Yi-Chih Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome
- (2018) Murat Alan et al. GYNECOLOGICAL ENDOCRINOLOGY
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
- (2018) Magdalena Wiecek et al. Frontiers in Physiology
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Asprosin — new hormone involved in hepatic glucose release
- (2016) Claire Greenhill Nature Reviews Endocrinology
- Early chronic kidney disease: diagnosis, management and models of care
- (2015) Olivier J. Wouters et al. Nature Reviews Nephrology
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Risk Prediction Models for Patients With Chronic Kidney Disease
- (2013) Navdeep Tangri et al. ANNALS OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started